Therapeutic strategies in systemic necrotizing vasculitides

Acta Clinica Belgica

Volumn 56, Issue 2, 2001, Pages 103-112

  Guillevin, L ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

CONFERENCE PAPER; CRYOGLOBULINEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NECROTIZING ARTERITIS; POLYARTERITIS NODOSA; VIRUS INFECTION; WEGENER GRANULOMATOSIS;

EID: 0035003064     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2001.018     Document Type: Conference Paper

References (67)

1. Cyclophosphamide-induced remission in advanced polyarteritis nodosa
2. Wegener granulomatosis: An analysis of 158 patients
3. Uber eine nicht bisher beschriebene eigenthümliche arterienerkrankung (Periarteritis Nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskelähmung einhergeht
4. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis angiitis)
5. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa
6. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
7. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
8. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment
9. Uber die nur mikroskopisch erkenbarre form der periarteritis nodosa
10. The kidney in periarteritis nodosa
11. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
12. Microscopic polyangiitis: Clinical and laboratory findings in 85 patients
13. Treatment of Wegener's granulomatosi: A prospective trial in 50 patients comparing prednisone, pulse cyclophosphamide versus prednisone and oral cyclophosphamide
14. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients
15. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases
16. Polyarteritis nodosa and parvovirus B 19 infection
17. A role for hepatitis C virus infection in type II cryoglobulinemia
18. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
19. Kawasaki syndrome with intravenous gammaglobulin
20. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients
21. Long term follow-up of polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome: Analysis of 4 prospective trials in 278 patients
22. Disease assessment and management of the vasculitides
23. European therapeutic trials in ANCA-associated systemic vasculitis: Disease scoring, consensus regimens and proposed clinical trials
24. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients
25. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: Comparison of steroids and oral or pulse cyclophosphamide in 25 patients
26. Treatment of systemic vasculitis with cyclophosphamide and steroids: Daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients
27. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis
28. Cyclophosphamide pulses in the treatment of rheumatic diseases: An update
29. Pharmacokinetics of cyclophosphamide in patients with systemic necrotizing angiitis
30. New developments in the treatment of systemic vasculitis
31. Classification and management of necrotizing vasculitides
32. Renal vasculitis: Microscopic polyarteritis and Wegener's granulomatosis
33. A multicentre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (CYCAZAREM)
34. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate
35. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole
36. A staged approach in the treatment of Wegener's granulomatosis: Induction with glucocorticoids and daily cyclophosphamide switching to methorexate for remission maintenance
37. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy
38. Leflunomide, a new promising agent in maintenance of remission in Wegener's granulomatosis
39. Immune ablation with peripheral stem cell rescue in Wegener's: Systemic vasculitis
40. Intravenous immunoglobulin as sole therapy for systemic vasculitis
41. Mixed cryoglobulinemia secondary to hepatitis C virus infection
42. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis
43. Treatment of primary systemic vasculitis
44. Effectiveness of cyclophosphamide pulse treatment in Wegener's granulomatosis
45. Infectious complications of cyclophosphamide treatment for vasculitis
46. Microscopic polyarteritis: Presentation, pathology and prognosis
47. Necrotizing vasculitis - Relapse despite cytotoxic therapy
48. Monoclonal-antibody therapy in systemic vasculitis
49. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients
50. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Clinical aspects, neurologic manifestations, and treatment
51. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
52. Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis
53. Therapeutic plasma exchange in renal diseases
54. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha
55. Interferon-alpha in mixed cryoglobulinemia patients. A randomized crossover-controlled trial
56. Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies
57. Vasculitis infection with the human immunodeficiency virus
58. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation
59. Pathologic features of AIDS encephalopathy in children
60. Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome
61. Eosinophilic vasculitis leading to amaurosis fugax in a patient with AIDS
62. Lymphomatoid granulomatosis and the acquired immunodeficiency syndrome
63. The rheumatic manifestations of infection with the human imunodeficiency virus
64. Vascularite leucocytoclasique et virus de l'immunodeficience humaine: Deux nouvelles observations
65. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis
66. Pneumocystis carinii pneumonia in the course of connective tissue disease: Report of 34 cases
67. Damage occurs early in systemic vasculitis and is an index of outcome